Full Year 2025 Chrysos Corporation Ltd Earnings Call Transcript
Key Points
- Chrysos Corp Ltd (CHRCF) reported a significant revenue increase of 46% year-over-year, reaching $66.1 million, driven by the strong adoption of PhotonAssay technology.
- EBITDA grew by 80% compared to the previous year, reaching $16.1 million, with margins improving from 20% to 24%.
- The company achieved geographic diversification, with international non-APAC operations now representing 65% of total revenue, reducing concentration risk.
- PhotonAssay unit costs remain within the target gross margin range of 70% to 80%, supported by the hub strategy and increased in-house maintenance capabilities.
- Operating cash flow increased from $3.6 million to $8.8 million, reflecting the company's growing global footprint and improved cash conversion from EBITDA.
- The international tax position delayed the full financial results release, with a tax expense recorded at $5.3 million, impacting the financial statements.
- The company faces additional costs associated with entering new regions, including potential increases in headcount and advisory fees.
- Despite revenue growth, operating expenses increased by 35%, which could pressure future profitability if not managed effectively.
- Trade receivables have increased in line with deployments and industry cycles, which may impact cash flow if not managed properly.
- The company has drawn $17.4 million of debt with an additional $10.9 million drawn post year-end, which could increase financial leverage and interest obligations.
Good day and welcome to the Chrysos Corporation FY25 result call. (Operator Instructions) And finally, I would like to advise all participants that this call is being recorded.
Thank you. I'd now like to welcome Brett Coventry, CFO, to begin the conference. Brett, over to you.
Good morning, shareholders. Thank you all for joining us today for the presentation of our audited financial results for the year ended June 30, 2025. I'm joined by our Managing Director and CEO, Dirk Treasure, who will take part in the Q&A at the end of this presentation. There is no operational update, and the operational slides from the trading update are unchanged. We are now including the financial slides, which I will be presenting.
Our international tax position that delayed the full financial results release and which we have provided guidance as to the tax expense being in the range of $5 million to $10 million. We are pleased to confirm this ended at the lower end of the range at $5.3
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

